BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35159173)

  • 1. Stem Cell Factor SOX9 Interacts with a Cell Death Regulator RIPK1 and Results in Escape of Cancer Stem Cell Death.
    Oh M; Son C; Rho SB; Kim M; Park K; Song SY
    Cells; 2022 Jan; 11(3):. PubMed ID: 35159173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SOX9 Regulates Cancer Stem-Like Properties and Metastatic Potential of Single-Walled Carbon Nanotube-Exposed Cells.
    Voronkova MA; Luanpitpong S; Rojanasakul LW; Castranova V; Dinu CZ; Riedel H; Rojanasakul Y
    Sci Rep; 2017 Sep; 7(1):11653. PubMed ID: 28912540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SOX9-activated FARSA-AS1 predetermines cell growth, stemness, and metastasis in colorectal cancer through upregulating FARSA and SOX9.
    Zhou T; Wu L; Ma N; Tang F; Yu Z; Jiang Z; Li Y; Zong Z; Hu K
    Cell Death Dis; 2020 Dec; 11(12):1071. PubMed ID: 33318478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD73 sustained cancer-stem-cell traits by promoting SOX9 expression and stability in hepatocellular carcinoma.
    Ma XL; Hu B; Tang WG; Xie SH; Ren N; Guo L; Lu RQ
    J Hematol Oncol; 2020 Feb; 13(1):11. PubMed ID: 32024555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MAFB Promotes Cancer Stemness and Tumorigenesis in Osteosarcoma through a Sox9-Mediated Positive Feedback Loop.
    Chen Y; Wang T; Huang M; Liu Q; Hu C; Wang B; Han D; Chen C; Zhang J; Li Z; Liu C; Lei W; Chang Y; Wu M; Xiang D; Chen Y; Wang R; Huang W; Lei Z; Chu X
    Cancer Res; 2020 Jun; 80(12):2472-2483. PubMed ID: 32234710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incomplete radiofrequency ablation promotes the development of CD133
    Yuan CW; Wang ZC; Liu K; Liu DJ
    Hepatobiliary Pancreat Dis Int; 2018 Oct; 17(5):416-422. PubMed ID: 30262419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SLUG is required for SOX9 stabilization and functions to promote cancer stem cells and metastasis in human lung carcinoma.
    Luanpitpong S; Li J; Manke A; Brundage K; Ellis E; McLaughlin SL; Angsutararux P; Chanthra N; Voronkova M; Chen YC; Wang L; Chanvorachote P; Pei M; Issaragrisil S; Rojanasakul Y
    Oncogene; 2016 Jun; 35(22):2824-33. PubMed ID: 26387547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-613 inhibits liver cancer stem cell expansion by regulating SOX9 pathway.
    Li B; Liu D; Yang P; Li HY; Wang D
    Gene; 2019 Jul; 707():78-85. PubMed ID: 31075412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SOX9/FXYD3/Src Axis Is Critical for ER
    Xue Y; Lai L; Lian W; Tu X; Zhou J; Dong P; Su D; Wang X; Cao X; Chen Y; Wang Q
    Mol Cancer Res; 2019 Jan; 17(1):238-249. PubMed ID: 30206184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA DUXAP9 promotes hepatocellular carcinoma cell stemness via directly interacting with sox9.
    Zeng R; Wang C; Wang W; Wang S
    Environ Toxicol; 2021 Sep; 36(9):1793-1801. PubMed ID: 34086387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex Determining Region Y Box 9 Induces Chemoresistance in Pancreatic Cancer Cells by Induction of Putative Cancer Stem Cell Characteristics and Its High Expression Predicts Poor Prognosis.
    Higashihara T; Yoshitomi H; Nakata Y; Kagawa S; Takano S; Shimizu H; Kato A; Furukawa K; Ohtsuka M; Miyazaki M
    Pancreas; 2017; 46(10):1296-1304. PubMed ID: 28984791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SOX9 Is Essential for Triple-Negative Breast Cancer Cell Survival and Metastasis.
    Ma Y; Shepherd J; Zhao D; Bollu LR; Tahaney WM; Hill J; Zhang Y; Mazumdar A; Brown PH
    Mol Cancer Res; 2020 Dec; 18(12):1825-1838. PubMed ID: 32661114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA THOR increases the stemness of gastric cancer cells via enhancing SOX9 mRNA stability.
    Song H; Xu Y; Shi L; Xu T; Fan R; Cao M; Xu W; Song J
    Biomed Pharmacother; 2018 Dec; 108():338-346. PubMed ID: 30227327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RIPK1 binds to vitamin D receptor and decreases vitamin D-induced growth suppression.
    Quarni W; Lungchukiet P; Tse A; Wang P; Sun Y; Kasiappan R; Wu JY; Zhang X; Bai W
    J Steroid Biochem Mol Biol; 2017 Oct; 173():157-167. PubMed ID: 28159673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The SOX9-Aldehyde Dehydrogenase Axis Determines Resistance to Chemotherapy in Non-Small-Cell Lung Cancer.
    Voronkova MA; Rojanasakul LW; Kiratipaiboon C; Rojanasakul Y
    Mol Cell Biol; 2020 Jan; 40(2):. PubMed ID: 31658996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sox9 regulates self-renewal and tumorigenicity by promoting symmetrical cell division of cancer stem cells in hepatocellular carcinoma.
    Liu C; Liu L; Chen X; Cheng J; Zhang H; Shen J; Shan J; Xu Y; Yang Z; Lai M; Qian C
    Hepatology; 2016 Jul; 64(1):117-29. PubMed ID: 26910875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 7-Hydroxycoumarin protects against cisplatin-induced acute kidney injury by inhibiting necroptosis and promoting Sox9-mediated tubular epithelial cell proliferation.
    Wu WF; Wang JN; Li Z; Wei B; Jin J; Gao L; Li HD; Li J; Chen HY; Meng XM
    Phytomedicine; 2020 Apr; 69():153202. PubMed ID: 32169782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The neurotoxicant PCB-95 by increasing the neuronal transcriptional repressor REST down-regulates caspase-8 and increases Ripk1, Ripk3 and MLKL expression determining necroptotic neuronal death.
    Guida N; Laudati G; Serani A; Mascolo L; Molinaro P; Montuori P; Di Renzo G; Canzoniero LMT; Formisano L
    Biochem Pharmacol; 2017 Oct; 142():229-241. PubMed ID: 28676433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SOX9-regulated cell plasticity in colorectal metastasis is attenuated by rapamycin.
    Carrasco-Garcia E; Lopez L; Aldaz P; Arevalo S; Aldaregia J; Egaña L; Bujanda L; Cheung M; Sampron N; Garcia I; Matheu A
    Sci Rep; 2016 Aug; 6():32350. PubMed ID: 27571710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a stemness-related gene panel associated with BET inhibition in triple negative breast cancer.
    Serrano-Oviedo L; Nuncia-Cantarero M; Morcillo-Garcia S; Nieto-Jimenez C; Burgos M; Corrales-Sanchez V; Perez-Peña J; Győrffy B; Ocaña A; Galán-Moya EM
    Cell Oncol (Dordr); 2020 Jun; 43(3):431-444. PubMed ID: 32166583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.